Selective mTOR inhibition via FLCN drives TFE3-dependent VLDL-TG secretion and protects from MAFLD/MASH
Hepatic lipid homeostasis is controlled by multiple processes, including VLDL-TG secretion. We have previously shown that the FLCN/TFE3 branch of mTORC1 signaling controls hepatic fatty acid oxidation and de novo lipogenesis to protect mice from MAFLD. We now show that the FLCN/TFE3 pathway also controls VLDL-TG secretion via direct transcriptional activation of a broad program of genes involved in VLDL-TG secretion, including PCYT1A, the rate-limiting step of phosphatidylcholine synthesis. Loss of hepatic FLCN upregulates VLDL-TG secretion and prevents MAFLD, and this protection requires TFE3 and PCYT1A. The data unveil a new pathway that orchestrates multiple steps of VLDL-TG synthesis and secretion. The data also highlight that suppressing the selective FLCN/TFE3 branch of mTORC1 signaling maximizes hepatic lipid clearance by coordinately promoting fatty acid oxidation, suppressing de novo lipogenesis, and boosting VLDL-TG secretion, providing an attractive therapeutic target for the treatment of MAFLD.
Authors
- Wei Zhou (ORCID: https://orcid.org/0000-0001-9607-4490)
- Bridget S. Gosis (ORCID: https://orcid.org/0000-0003-0068-621X)
- Zoltan Pierre Arany (ORCID: https://orcid.org/0000-0003-1368-2453)
- Cholsoon Jang (ORCID: https://orcid.org/0000-0001-6651-4213)
- Kristina Li (ORCID: https://orcid.org/0000-0002-4417-0998)
- Aalim M. Weljie (ORCID: https://orcid.org/0000-0002-7145-4494)
- Jae Woo Jung (ORCID: https://orcid.org/0000-0001-7178-7400)
- Chelsea L. Thorsheim (ORCID: https://orcid.org/0000-0002-5990-4165)
- Paul M. Titchenell (ORCID: https://orcid.org/0000-0002-9941-5649)
- Daniel James Boehmler (ORCID: https://orcid.org/0000-0003-3207-4883)
- Megan C. Blair
- Arin Cox (ORCID: https://orcid.org/0000-0003-1841-8512)
- Jessie Axsom (ORCID: https://orcid.org/0000-0002-8013-9576)
- Gabriel C. Durso
- Sho Tanosaki
Institutions
- University of California, Irvine (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1038/s41467-026-79397-6
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Pennsylvania
- National Institutes of Health
- National Heart, Lung, and Blood Institute